Alternative Approaches to Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention, How Do They

Ryaan El-Andari1, Sabin J Bozso1, Nicholas M Fialka2

  • 1From the Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, AB, Canada.

Cardiology in Review
|January 23, 2023
PubMed

Insights

Alternative coronary artery bypass grafting (ACABG) shows favorable long-term outcomes, including survival and reduced adverse events, compared to percutaneous coronary intervention (PCI) for severe coronary artery disease.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Technology

Background:

  • Coronary artery disease (CAD) remains a primary global cause of mortality.
  • Severe symptomatic CAD necessitates interventions like coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).
  • Alternative CABG (ACABG) techniques are gaining traction to mitigate CABG's early risks.

Purpose of the Study:

  • To systematically review and meta-analyze contemporary literature comparing outcomes of ACABG versus PCI.
  • To evaluate long-term survival, major adverse cardiovascular and cerebrovascular events (MACCE), myocardial infarction (MI), and repeat revascularization rates.

Main Methods:

  • Systematic literature search of Pubmed, Medline, and Embase.
  • Inclusion of 11 studies after screening 1154 articles.
  • Meta-analysis performed using RevMan 5.4 software for pooled data analysis.

Main Results:

  • Individual studies indicated ACABG favored or showed no significant difference in long-term survival, MACCE, MI, and repeat revascularization.
  • Pooled data analysis revealed ACABG favored rates for MACCE, MI, and repeat revascularization.
  • ACABG demonstrated favorable long-term mortality, MACCE, MI, and repeat revascularization with similar short-term mortality and stroke rates compared to PCI.

Conclusions:

  • ACABG presents favorable long-term outcomes and comparable short-term safety to PCI for severe CAD.
  • Continued advancements in both CABG and PCI are improving patient results.
  • Further direct comparative studies and exploration of hybrid revascularization are warranted.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
14